Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    today
    Change Detected
    Summary
    Medicenna’s news-release list now features an October 26, 2026 announcement reporting CD122 blockade and extended survival with MDNA209 in preclinical autoimmune disease models. The August 14, 2026 release on first-quarter fiscal 2027 financial results and upcoming conference presentations is no longer listed.
    Difference
    3%
    Check dated 2026-11-01T02:22:24.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A new October 22, 2026 news release announces Medicenna’s planned presentation of preclinical data on its CD122 superantagonist MDNA209. The June 26, 2026 fiscal-year results and operational-highlights release is no longer listed.
    Difference
    3%
    Check dated 2026-10-25T02:24:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The news releases list now features Medicenna’s October 5, 2026 announcement of an oral presentation of topline ABILITY-1 study data at SITC 2026. The June 11, 2026 release about newly issued and allowed patents has been removed from the displayed list.
    Difference
    3%
    Check dated 2026-10-11T03:13:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The news releases list now includes Medicenna’s October 1, 2026 announcement of the results of its Annual General and Special Meeting of Shareholders. The June 3, 2026 release about MDNA11 and the NEO-CYT trial presentation at ASCO 2026 is no longer listed.
    Difference
    3%
    Check dated 2026-10-04T02:39:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new press release dated September 24, 2026 announcing Bizaxofusp results at the 2026 Society for Neuro-Oncology Annual Meeting has been added to the News Releases. A May 28, 2026 press release about the closing of a public offering has been removed.
    Difference
    3%
    Check dated 2026-09-27T02:32:06.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new News Release entry announcing Medicenna's presentation at the H.C. Wainwright 28th Annual Global Investment Conference on September 3, 2026 has been added, and the May 22, 2026 release about the prospectus supplement and investment term sheet has been removed.
    Difference
    4%
    Check dated 2026-09-05T22:15:36.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.